Morning Market Gainers

Atmel Corporation ATML shares jumped 13.89 percent to $8.28 after Dialog Semiconductor Plc DLGNF announced its plans to acquire Atmel for around $4.6 billion. Galectin Therapeutics Inc GALT rose 6.83 percent to $2.44. H.C. Wainwright initiated coverage on Galectin Therapeutics with a Buy rating and a $7.00 price target. Uniqure NV QURE shares surged 6.05 percent to $35.43 following Saturday announcement of positive topline results from Phase I/II trial in Sanfilippo B syndrome patients using AAV5-based gene therapy. CytRx Corporation CYTR shares gained 5.79 percent to $3.01 after the company reported the publication of its positive global Phase 2b clinical trial results for soft tissue sarcoma in the peer-reviewed JAMA Oncology. AcelRx Pharmaceuticals Inc ACRX shares gained 5.29 percent to $4.18 after PDL BioPharma Inc PDLI announced the acquisition of portion of AcelRx Pharma's expected royalties and milestones from Zalviso for $65 million. Allot Communications Ltd ALLT surged 4.49 percent to $5.12 after the company reported that it has received an $8 million expansion order from a tier-1 operator. Shire PLC (ADR) SHPG shares rose 2.47 percent to $223.89 following announcement of EC approval of non-stimulant ADHD treatment. Lennar Corporation LEN shares gained 2.26 percent to $52.93 after the company reported stronger-than-expected results for its fiscal third quarter.